ADAM GRISAK: Open Payments
NPI 1881014645 · CINCINNATI, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,460 in 75 payments from 14 companies in 2025. Trend: 2023 $1,777 · 2024 $2,097 · 2025 $1,460
Food & beverage: $1,460
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $336 |
| Novo Nordisk Inc | 15 | $330 |
| PFIZER INC. | 15 | $190 |
| AstraZeneca Pharmaceuticals LP | 4 | $183 |
| Axsome Therapeutics, Inc. | 4 | $101 |
| Lilly USA, LLC | 3 | $57 |
| Astellas Pharma US Inc | 2 | $50 |
| Exact Sciences Corporation | 2 | $47 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $43 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $31 |
Products named: Ozempic, UBRELVY, FARXIGA, VRAYLAR, Auvelity, NURTEC ODT, JARDIANCE, QULIPTA.
Industry payments across OH — which companies pay providers there.
